Covered recipient · General Payments record
JULIE A REEVES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,527.06
- Reported across 102 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $214.68 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $51.20 | 3 |
| Corium, Inc. | $50.37 | 4 |
| Currax Pharmaceuticals LLC | $28.48 | 2 |
| Amgen Inc. | $20.27 | 1 |
| Merck Sharp & Dohme Corporation | $19.16 | 1 |
| Lilly USA, LLC | $16.48 | 1 |
| PFIZER INC. | $14.37 | 1 |
| GlaxoSmithKline, LLC. | $14.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $20.27 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111686147 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.86 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104572016 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.33 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104437333 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.01 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104571806 | CMS |
| Corium, LLC | $15.47 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100111558 | CMS |
| Corium, LLC | $14.50 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100114176 | CMS |
| Corium, LLC | $8.79 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100125170 | CMS |
| Corium, LLC | $11.61 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100218599 | CMS |
| Currax Pharmaceuticals LLC | $13.44 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089512134 | CMS |
| Currax Pharmaceuticals LLC | $15.04 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089512136 | CMS |
| GlaxoSmithKline, LLC. | $14.35 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116594188 | CMS |
| Lilly USA, LLC | $16.48 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135100672 | CMS |
| Merck Sharp & Dohme LLC | $19.16 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141919338 | CMS |
| PFIZER INC. | $14.37 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132089367 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.